Davide Bernareggi

541 total citations
12 papers, 410 citations indexed

About

Davide Bernareggi is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Davide Bernareggi has authored 12 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Davide Bernareggi's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers) and RNA Interference and Gene Delivery (3 papers). Davide Bernareggi is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers) and RNA Interference and Gene Delivery (3 papers). Davide Bernareggi collaborates with scholars based in United States, Norway and Sweden. Davide Bernareggi's co-authors include Dan S. Kaufman, Zhu Huang, Eivind Heggernes Ask, Hanna Julie Hoel, Karl‐Johan Malmberg, Zhipeng Meng, ZhengMing Wu, Robert Blum, Chengsheng Wu and Kun‐Liang Guan and has published in prestigious journals such as Nature Communications, Blood and Cancer Research.

In The Last Decade

Davide Bernareggi

11 papers receiving 403 citations

Peers

Davide Bernareggi

IMMUN

ONCOL

HEMAT

Michelle L. Swearingen United States

Stina L. Wickström Sweden

Liaomin Peng United States

Sergey Nechaev United States

Djem Kissiov United States

Alexandra L. Pourzia United States

Zuzanna Urban‐Wójciuk Poland

Madeline A. Hwee United States

Sanaz Taromi Germany

Marius Messemaker Switzerland

Michelle L. Swearingen United States

Davide Bernareggi

346 ×1.3

IMMUN

335 ×1.3

ONCOL

95 ×0.7

29 ×0.9

42 ×1.6

HEMAT

Citations per year, relative to Davide Bernareggi Davide Bernareggi (= 1×) peers Michelle L. Swearingen

Countries citing papers authored by Davide Bernareggi

Since Specialization

Citations

This map shows the geographic impact of Davide Bernareggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Bernareggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Bernareggi more than expected).

Fields of papers citing papers by Davide Bernareggi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Bernareggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Bernareggi. The network helps show where Davide Bernareggi may publish in the future.

Co-authorship network of co-authors of Davide Bernareggi

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Bernareggi. A scholar is included among the top collaborators of Davide Bernareggi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Bernareggi. Davide Bernareggi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Bernareggi, Davide, et al.. (2023). Abstract 2919: A novel method for clinical scale production of natural killer cells from clonal master induced pluripotent stem cells with CISH knockout for next generation, off-the-shelf cancer immunotherapy. Cancer Research. 83(7_Supplement). 2919–2919. 1 indexed citations

Bernareggi, Davide, et al.. (2023). Human iPSC-Derived NK Cells with Knock-in of the BCL2 G101V Mutation Are Resistant to Venetoclax and Demonstrate Improved Anti-AML Activity In Vivo. Blood. 142(Supplement 1). 464–464. 1 indexed citations

Bernareggi, Davide, Qi Xie, Briana C. Prager, et al.. (2022). CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity. Nature Communications. 13(1). 1899–1899. 46 indexed citations

Bernareggi, Davide, Caryn S. Gonsalves, Luis A. Solchaga, et al.. (2022). Abstract 3151: A novel method to produce clinical scale induced pluripotent stem cell-derived natural killer (iPSC-NK) cells with improved anti-tumor activity for next-generation allogenic cell therapies. Cancer Research. 82(12_Supplement). 3151–3151.

Bernareggi, Davide, et al.. (2022). 336 A novel method for efficient cGMP production of natural killer cells from clonal master induced pluripotent stem cells for next generation, off-the-shelf cancer immunotherapy. Regular and Young Investigator Award Abstracts. A354–A354. 1 indexed citations

Bernareggi, Davide, et al.. (2022). Knock-in of the BCL2 G101V Mutation in Human iPSC-Derived NK Cells Generates Venetoclax Resistance and Improves Activity Against Venetoclax Resistant AML. Blood. 140(Supplement 1). 7407–7408. 2 indexed citations

Huang, Zhu, Davide Bernareggi, Eivind Heggernes Ask, et al.. (2020). Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles. Frontiers in Immunology. 11. 561553–561553. 51 indexed citations

Huang, Zhu, Robert Blum, Davide Bernareggi, et al.. (2020). Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity. Cell stem cell. 27(2). 224–237.e6. 233 indexed citations

Huang, Zhu, Robert Blum, Davide Bernareggi, et al.. (2020). Metabolic Reprograming Due to Deletion of <i>CISH</i> in Human Natural Killer Cells Promotes <i>in vivo</i> Persistence and Enhances Anti-Tumor Activity. SSRN Electronic Journal. 1 indexed citations

10.

Bernareggi, Davide, et al.. (2020). Abstract PR03: Use of CRISPR knockout screen to identify genes that regulate tumor cell sensitivity to NK cell-based immunotherapy. Cancer Research. 80(11_Supplement). PR03–PR03. 1 indexed citations

11.

Bernareggi, Davide, Somayeh Pouyanfard, & Dan S. Kaufman. (2019). Development of innate immune cells from human pluripotent stem cells. Experimental Hematology. 71. 13–23. 46 indexed citations

12.

Quarta, Alessandra, Davide Bernareggi, Fabio Benigni, et al.. (2014). Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo. Nanoscale. 7(6). 2336–2351. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact